Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
MGRXMangoceuticals, Inc.
| Figure | MGRXMangoceuticals, Inc.FY2025 · Dec |
|---|---|
| Revenue | $456.02K |
| Revenue, yoy | −26.0% |
| Net income | $20.64M |
| Net income, yoy | −137.1% |
| Net margin | -4,526.8% |
| Free cash flow | $7.00M |
| FCF margin | — |
| EPS, diluted | $2.17 |
Add another company.
Annual · FY2022–FY2025 · USD
From SEC EDGARSame fiscal periods, as filed